Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

EU Debt Crisis Adds Uncertainty

The sovereign debt crisis in the EU could greatly change the landscape for contract services.
Jul 7, 2010

The sovereign debt crisis in the EU could greatly change the landscape for contract services.

Be Careful for What You Wish

Rising labor costs in China may result in increased competition for higher value services.
Jul 2, 2010

Rising labor costs in China may result in increased competition for higher value services.

Be Careful What You Wish For

Jul 1, 2010

Rising labour rates in China may reduce its cost advantage, but will probably result in western suppliers facing more competition for higher value services.

EU Debt Crisis Adds Uncertainty

The sovereign debt crisis in the EU could greatly change the landscape for contract services.
Jun 2, 2010

The sovereign debt crisis in the EU could greatly change the landscape for contract services.

EU debt crisis adds uncertainty for contract services

Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments. CMOs will feel the effect of this in fewer batches and increased pressure to reduce prices.
Jun 1, 2010

Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments.

The Lilly Way

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 5, 2010

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.

The Lilly Way

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 2, 2010

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.

The Lilly Way

Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.
May 1, 2010

Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.

Time for a Model Upgrade

CMOs' business model has all of the flaws of the captive model it is meant to replace.
Apr 7, 2010

CMOs' business model has all of the flaws of the captive model it is meant to replace.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here